| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 155,995 | 130,190 | 155,455 | 224,076 | | Cost of Revenue | 112,441 | 98,020 | 115,197 | 164,299 | | | Gross Profit | 43,554 | 32,170 | 40,258 | 59,777 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 39,299 | 44,845 | 48,416 | 48,312 | | Non Recurring | 54 | 14 | 90,084 | 13,357 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,201 | (12,689) | (98,242) | (1,892) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (72) | 504 | (2,959) | (29) | | Earnings Before Interest And Taxes | 4,129 | (12,185) | (101,201) | (1,921) | | Interest Expense | 253 | 207 | (994) | 1,725 | | Income Before Tax | 3,876 | (12,392) | (100,207) | (3,646) | | Income Tax Expense | 988 | 15 | 14,385 | (1,401) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,888 | (12,407) | (114,592) | (2,245) | | | Non-recurring Events | | Discontinued Operations | (52) | 11 | 804 | (1,477) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,836 | (12,396) | (113,788) | (3,722) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,836 | ($12,396) | ($113,788) | ($3,722) |
|
0.51% Nasdaq 
0.02 (0.21%) 
Income Statement
